MHLW Proposes Penalty for Companies that Receive Premium but Refuse Development Requests

The CSIMC's Expert Subcommittee on NHI Drug Pricing Affairs The Ministry of Health, Labor and Welfare (MHLW; Korosho ) proposed a number of new rules in respect to the premium for new drug development and elimination of off-label drug use...read more